SCHEMBL5582167

SCHEMBL5582167

COc1c(CC(=O)O)cc(-c2cccc(Cl)c2)c2cnc(N(C)C)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ PTGDR2 Q9Y5Y4 3/20 0.39
▸ SLC6A9 P48067 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ LTB4R Q15722 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ CTSA P10619 4/20 0.36
▸ DGAT2 Q96PD7 1/20 0.36
▸ CETP P11597 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ GRIN2B Q13224 2/20 0.36
▸ NUDT1 P36639 1/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582222 0.91 KDM4E (0.40) KDM4EALDH1A1MAPTHPGDSLC6A9
SCHEMBL5582173 0.85 MAPT (0.42) KDM4EALDH1A1MAPTHPGDLTB4R
SCHEMBL5582263 0.83 ALDH1A1 (0.38) KDM4EALDH1A1MAPTHPGDSLC6A9
SCHEMBL5582259 0.83 ALDH1A1 (0.38) KDM4EALDH1A1MAPTHPGDSLC6A9
SCHEMBL5581766 0.83 KDM4E (0.40) KDM4EALDH1A1MAPTHPGDADORA1
SCHEMBL5581841 0.83 NPC1 (0.41) KDM4EALDH1A1MAPTHPGDLTB4R
SCHEMBL5581974 0.82 MAP4K4 (0.45) KDM4EALDH1A1MAPTHPGDSLC6A9
SCHEMBL5582081 0.81 CETP (0.38) KDM4EALDH1A1MAPTHPGDSLC6A9
SCHEMBL5582200 0.81 MAPT (0.43) KDM4EALDH1A1MAPTHPGDADORA1
SCHEMBL5581833 0.80 MAP4K4 (0.39) KDM4EALDH1A1MAPTHPGDADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225308-A1 2-Amino Quinazoline Derivative KYOWA HAKKO KOGYO CO.,LTD. (JP) 2007-09-27 — — US disclosed
EP-1726584-A1 2-AMINOQUINAZOLINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-11-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225308-A1 2-Amino Quinazoline Derivative AGTR2, ABL1, AGTR1 KDM4E 1708/4885ALDH1A1 1519/4885MAPT 4096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback